FDA Mistakenly Identifies Green Roads LLC in Warning Letter

The Food and Drug Administration agency has made a press release warning cannabis companies not to market their product as “cancer-treating” or “cancer-killing” drugs as those claims have not (yet) been confirmed by the FDA.

In their press release, the FDA made a mistake identifying the company called Greenroads Health as Green Roads of Florida LLC.

The FDA followed this up with a letter addressed to Green Roads of Florida LLC  and Ms. Laura Fuentes — CEO of Green Roads of Florida, warning them not to brand their product online as a cancer-curing drug.

This is to advise you that the Food and Drug Administration (FDA) reviewed your web site at the Internet address www.Greenroadhealth.com in February 2017

However, Ms. Fuentes has no affiliation with www.Greenroadhealth.com, nor does she claim any responsibility for the content posted on that website, as her company produces purely CBD products which are legal in all 50 states.

Additionally, Green Roads products are made from professionally grown cannabis and made available by consulting with medical professionals.

The FDA claims that the confusion stems from the Green Roads Health unauthorized use of the “Green Roads” brand and graphics.

In an official announcement, Ms. Fuentes said:

“At Green Roads, we produce only the finest quality products, using the best ingredients, and we appreciate the continued outpouring of support and testimonials we have received from people who have reportedly benefited from our products.”

FDA crackdown on fake marketing

In their press release, aside from mistaking Greenroads Health, the FDA warned three other companies not to engage in fake advertisement and fraudulent product branding.

FDA Commissioner Scott Gottlieb, MD said: “There are a growing number of effective therapies for many cancers. When people are allowed to illegally market agents that deliver no established benefit they may steer patients away from products that have proven, anti-tumor effects that could extend lives.”

Here are some of the claims these 4 cannabis companies have made:

  • “Combats tumor and cancer cells;”
  • “CBD makes cancer cells commit ‘suicide’ without killing other cells;”
  • “CBD … [has] anti-proliferative properties that inhibit cell division and growth in certain types of cancer, not allowing the tumor to grow;” and
  • “Non-psychoactive cannabinoids like CBD (cannabidiol) may be effective in treating tumors from cancer – including breast cancer.”

As you may have noticed, the FDA really doesn’t want you to advertise cannabis as cancer treating because it has not yet been confirmed to be such.

Source: FDA and Green Roads LLC


Latest news from the US and Canada cannabis industry.

Leave a Comment